What is it about?
Bevacizumab is generally believed reverse resistance to chemotherapy in many cancers. Not suprisedly, we observed similar phenomenon in this case of NPC. Please read it for detail. Thanks!
Featured Image
Read the Original
This page is a summary of: Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review, OncoTargets and Therapy, December 2016, Dove Medical Press,
DOI: 10.2147/ott.s122238.
You can read the full text:
Contributors
The following have contributed to this page
